FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: amgn

Sort
E.g., 2013-05-19
E.g., 2013-05-19
Enter a comma separated list of user names.

 

Biotech has been a hot area in this market. Whether large cap or small cap, Wall Street and Main Street have watched as biotech companies have surged. This is partly due to the safety of drug stocks, along with the optimism of future drugs. Large cap biotech  Amgen, Inc. (NASDAQ:AMGN) continues to trade near its all time highs at $112.54, +1.16 (1.04%).

 

Healthcare Dividend Stocks With Highest Expected EPS Growth Researched By “long-term-investments.blogspot.com”. I like healthcare companies because the sector is a long-term growth area due to the ongoing aging population. The sector is a 46.1 trillion bet on stronger than expected health diseases with a current dividend yield of 3.20 percent.

I made a little screen of the best large capitalized stocks with the highest expected earnings per share growth for the next five years. The industry with the biggest earnings forecast is definitely the biotechnology industry, followed by medical appliances and equipment stocks. But those companies pay no dividends. I focused on stocks with a positive yield and a double digit earnings growth. Finally, fourteen companies remained of which all are currently recommended to buy. The mostly represented companies are from the healthcare plans industry.

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $69.63 where it was opened at $69.10 up 0.43 points or +0.62% by closing at $69.57.

Amgen Showed up and doing - NASDAQ:AMGN

Posted by tom on January 18th, 2012

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $68.47 where it was opened at $67.90 up 0.47 points or +0.70% by closing at $68.07.

Amgen, Inc marks Active Volume - NASDAQ:AMGN

Posted by tom on January 12th, 2012

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $66.45 where it was opened at $65.26 up 0.73 points or +1.11% by closing at $66.40.

Amgen with a Slight Rise - NASDAQ:AMGN

Posted by david on January 11th, 2012

Amgen, Inc (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. Amgen, Inc achieved its new 52 week high price of $65.70 where it was opened at $64.55 up 1.47 points or +2.29% by closing at $65.67.

Amgen, Inc Stocks Closed in Green - NASDAQ:AMGN

Posted by akki on December 23rd, 2011

Amgen, Inc. (NASDAQ:AMGN) is an independent biotechnology medicines company. Amgen discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology. Amgen, Inc.

Pages

ADVERTISE WITH US